CXCL12 and myocardial ischemia: SDF-1 promotes de novo vasculogenesis by enhancing the survival, migration, engraftment and differentiation of endothelial precursor cells [77], [78], [79], and supports therapeutic progenitor cell function in the treatment of myocardial ischemia[80], [81].